🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Multicenter Analysis of Different Approaches in Segmentectomies in Early-stage Lung Cancer

Recruitingn/aAges 18 Years - anyAllScientific Institute San Raffaele
NCT06737107 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The study is a retrospective, observational and multicentric study. The study describes robotic segmentectomies performed in four referred centers, with the aim to assess the perioperative compilications of robotic segmentectomies compared to video-assisted thoracoscopic surgery (VATS) and open approach.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Pre or post-operative diagnosis of NSCLC surgically treated with pulmonary segmentectomy from 1st January 2010 to the 31st to December 2023. * Age \> then 18 years at the moment of surgery Exclusion Criteria: * Age \< then 18 years at the moment of surgery * diagnosis other than NSCLC
💊

What it tests

  • Not listed
📍

Where

4 sites
Istituto Clinico Humanitas
Rozzano, Italy
Scientific Institute Ospedale San Raffaele
Milan, Italy
Istituto Europeo di Oncologia
Milan, Italy
Policlinico Universitario Agostino Gemelli
Rome, Italy
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy